Related Experiment Video
Updated: Mar 22, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
HIF-1α Silencing Inhibits the Growth of Osteosarcoma Cells by Inducing Apoptosis
Fei Lv1, Rui Du2, Wenqiang Shang1
1Department of Orthopedics, Jizhong Energy Fengfeng Group Hospital, Handan, Hebei.
Background:
Osteosarcoma (OS) is a malignant tumor of mesenchymal origin, which is generally locally aggressive and tends to produce early systemic metastases. Therefore, an identification of a novel therapeutic target is required.
Methods:
We investigated the effect of small interfering RNA (siRNA) targeting hypoxia-inducible factor 1α (HIF-1α) on the growth of Osteosarcoma MG-63 and U2-OS cells. Two cell-lines were transfected with various concentrations of HIF-1α or control siRNA, and the effect on HIF-1α expression was analyzed by using quantitative polymerase chain reaction and western blot analysis. The effects of HIF-1α siRNA on growth inhibition and apoptosis were then evaluated by standard methods.
Result:
HIF-1α siRNA treatment reduced HIF-1α mRNA and protein expression in MG-63 and U2-OS cells significantly. The downregulation of HIF-1α expression upregulated caspase-3 expression subsequently inhibited the growth of MG-63 and U2-OS cells and induced apoptosis of the two cells. Our in vitro data indicate that the downregulation of HIF-1α is capable of suppressing OS cells growth, through the induction of apoptosis. HIF-1α inhibition may be a new strategy for the treatment of Osteosarcoma.
Insights
Small interfering RNA (siRNA) targeting hypoxia-inducible factor 1α (HIF-1α) effectively suppressed osteosarcoma cell growth and induced apoptosis. This suggests HIF-1α inhibition is a promising therapeutic strategy for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) is a locally aggressive bone cancer with a high tendency for early metastasis.
- Novel therapeutic targets are crucial for effective osteosarcoma treatment.
Purpose of the Study:
- To investigate the therapeutic potential of targeting hypoxia-inducible factor 1α (HIF-1α) in osteosarcoma.
- To evaluate the effect of HIF-1α inhibition on osteosarcoma cell growth and apoptosis.
Main Methods:
- Utilized small interfering RNA (siRNA) to target HIF-1α expression in MG-63 and U2-OS osteosarcoma cell lines.
- Quantified HIF-1α mRNA and protein levels using quantitative PCR and Western blot analysis.
- Assessed cell growth inhibition and apoptosis induction following HIF-1α downregulation.
Main Results:
- HIF-1α siRNA significantly reduced HIF-1α mRNA and protein expression in both cell lines.
- Downregulation of HIF-1α led to increased caspase-3 expression.
- HIF-1α inhibition resulted in suppressed osteosarcoma cell growth and induced apoptosis.
Conclusions:
- In vitro data demonstrate that HIF-1α downregulation effectively inhibits osteosarcoma cell proliferation via apoptosis induction.
- HIF-1α represents a potential novel therapeutic target for osteosarcoma treatment.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:24Regulation of Angiogenesis and Blood Supply
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:23Abnormal Proliferation
02:15Experimental RNAi